Casey C. Case
Keine laufenden Positionen mehr
Karriereverlauf von Casey C. Case
Ehemalige bekannte Positionen von Casey C. Case
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SANGAMO THERAPEUTICS, INC. | Geschäftsführer | 01.01.1997 | 18.11.2005 |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.1997 | 18.11.2005 | |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.1993 | 01.01.1997 |
OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.1989 | 01.01.1993 |
Multispan, Inc.
Multispan, Inc. BiotechnologyHealth Technology Multispan, Inc. develops assay tools for G-protein coupled receptor (GPCR) for research applications. It offers GPCR cell line reagents for drug screening assays, compound profiling, and monoclonal antibody generation. The firm also offers GPCR cDNA Bank that provides clones for GPCR expression in mammalian cells; and high expression cell lines, as well as cell line development services. The company was founded by Helena Suyang Mancebo and Jeng-Horng Her in 2004 and is headquartered in Hayward, CA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 | - |
Ausbildung von Casey C. Case
University of California, Davis | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Sektoral
Health Technology | 4 |
Health Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Health Services |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Multispan, Inc.
Multispan, Inc. BiotechnologyHealth Technology Multispan, Inc. develops assay tools for G-protein coupled receptor (GPCR) for research applications. It offers GPCR cell line reagents for drug screening assays, compound profiling, and monoclonal antibody generation. The firm also offers GPCR cDNA Bank that provides clones for GPCR expression in mammalian cells; and high expression cell lines, as well as cell line development services. The company was founded by Helena Suyang Mancebo and Jeng-Horng Her in 2004 and is headquartered in Hayward, CA. | Health Technology |
- Börse
- Insiders
- Casey C. Case
- Erfahrung